Bart Vansteenkiste, Domino’s Global Life Sciences Sector Manager, has an 18-year history with the company, focusing on European Union Falsified Medicines Directive (FMD) legislation since 2011. He works with Domino’s European original equipment manufactuer (OEM) partners and trade associations including the European Federation of Pharmaceutical Industries and Associations and Medicines for Europe. Since 1978, Domino Printing Sciences has established a global reputation for the development and manufacture of coding, marking, and printing technologies, as well as its worldwide aftermarket products and customer services. Today, Domino offers one of the most comprehensive portfolios of complete end-to-end coding solutions spanning primary, secondary, and tertiary applications designed to satisfy the compliance and productivity requirements of manufacturers.